245 related articles for article (PubMed ID: 25713336)
1. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
[TBL] [Abstract][Full Text] [Related]
4. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1103-1110. PubMed ID: 35244686
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
9. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
10. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
[TBL] [Abstract][Full Text] [Related]
11. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
12. SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.
Ten LC; Chin YM; Tai MC; Chin EF; Lim YY; Suthandiram S; Chang KM; Ong TC; Bee PC; Mohamed Z; Gan GG; Ng CC
Sci Rep; 2017 Jan; 7():41400. PubMed ID: 28139690
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
14. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
Aissani B; Ogwaro KM; Shrestha S; Tang J; Breen EC; Wong HL; Jacobson LP; Rabkin CS; Ambinder RF; Martinez-Maza O; Kaslow RA
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):170-9. PubMed ID: 19654554
[TBL] [Abstract][Full Text] [Related]
15. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations.
Hosgood HD; Au WY; Kim HN; Liu J; Hu W; Tse J; Song B; Wong KF; Lee JJ; Chanock SJ; Siu LP; Purdue MP; Shin MH; Yu J; Liang R; Kim HJ; Rothman N; Lan Q
Int J Hematol; 2013 Jun; 97(6):793-9. PubMed ID: 23640160
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Ekström Smedby K; Vajdic CM; Falster M; Engels EA; Martínez-Maza O; Turner J; Hjalgrim H; Vineis P; Seniori Costantini A; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjosé S; Chiu BC; Dal Maso L; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W
Blood; 2008 Apr; 111(8):4029-38. PubMed ID: 18263783
[TBL] [Abstract][Full Text] [Related]
17. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
[TBL] [Abstract][Full Text] [Related]
18. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
Glass S; Phan A; Williams JN; Flowers CR; Koff JL
Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
[TBL] [Abstract][Full Text] [Related]
19. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
20. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]